![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 20, 2010 11:22:27 AM
"Now that we've completed the purchase of the BioHarp, the company has a clear path it will take to deliver this cutting-edge product to the healthcare community globally. Our intentions are to do the following:
1. Finalize the end product design relating to the device and software. This has already been agreed upon by management and we will look to have the finished product very shortly to begin sales to the veterinary, equine, and horticulture sectors.
2. Secure our manufacturing contracts so we can meet our anticipated needs of 20-30,000 units per month for 2010. (This number could rise dramatically based on our current contract conversations with several health organizations globally.)
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM